Skip to main content
OpenTrials
Completed

NCT Number: NCT02180568

Lipiodol Localization for Ground-glass-opacity Minimal Surgery

The study object is to demonstrate the usefulness and safety of lipiodol localization technique for individuals undergoing ground-glass opacity (GGO) Video-assisted thoracic surgery (VATS) resection compared to hook wire localization technique. A total of 250 participants will be enrolled in a 1:1 fashion to Lipiodol or Hook-wire groups. If the aims of this study are achieved, the use of lipiodol localization technique will be widespread their application for localization of non-palpable pulmonary lesions that are indicated for VATS resection.

Completed

Looking for future studies?

Notify Me

Key information

Age range

20 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Yonsei University Health System, Severance Hospital

Seoul, 120-752, South Korea

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Consenting adult patients ≥ 20 years of age
  • Pulmonary lesion with a ground glass opacity(GGO)component of more than 50%
  • Patient with lesion size less than 3cm
  • Persistence or growth of the established lesion within a three month period
  • Patient who are not contraindicated to surgery
  • Patients who are willing to sign the informed consent form

Exclusion criteria

  • Patients with solid pulmonary lesion
  • Patients with multiple GGOs need multiple localization
  • Patients who are contraindicated to surgery
  • Patients who behave in an uncooperative manner
  • Unwilling or unable to give informed consent
  • Pregnant women

Treatment and study plan

Lipiodol

Procedure

Lipiodol-guided lung localization technique

Hookwire

Procedure

Hookwire-guided lung localization technique

Lipiodol

Drug

Primary outcomes

  1. Procedure success rate

    Time frame: one day

    Procedure success was defined as marking (lipiodol or hook-wire) the GGO lesion within 1 cm without pleural leakage of lipiodol or dislodgement of the hook-wire.

Secondary outcomes

  1. Complication rate

    Time frame: one day

    Procedure-related complications such as pneumothorax, lung hemorrhage, hemoptysis, air-embolism and death

  2. Procedure time

    Time frame: 1 hour

    Total procedure time for lung localization

  3. Surgery time

    Time frame: 12 hours

    Surgery time for obtaining wedge resection specimen

  4. Safety resection margin

    Time frame: 1 hour

    The safety specimen resection margin was categorized either as positive (grossly positive (R2), microscopically positive if tumor was at the inked surface (R1)), or negative (microscopically negative if there was no tumor at the inked surface (R0))

Sponsors and collaborators

Lead sponsor

Severance Hospital

Other

Collaborators

  • Asan Medical Center
  • Chung-Ang University Hospital
  • Dankook University
  • Gangnam Severance Hospital
  • Korea University Anam Hospital
  • Pusan National University Hospital
  • Wonju Severance Christian Hospital

Registry information

Official study title

Validation Study to Evaluate the Safety and Efficacy of Preoperative Computed Tomography-guided Localization Technique Using Lipiodol for Patients With Ground Glass Opacity Pulmonary Lesions: A Prospective Multicenter Study

Acronym: LOGIS

Important dates

Study start
2014
Primary completion
2016
Study completion
2017
First posted
Jul 2, 2014
Registry last updated
Mar 22, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.